Variant report

Variant	nsv823471
Chromosome Location	chr6:30483102-30483978
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr6:30483891-30484544	K562	blood:	n/a	n/a
2	ARID3A	chr6:30483890-30484185	HepG2	liver:	n/a	n/a
3	ATF1	chr6:30483831-30484574	K562	blood:	n/a	n/a
4	ATF2	chr6:30483860-30484685	GM12878	blood:	n/a	n/a
5	ATF2	chr6:30483894-30484637	GM12878	blood:	n/a	n/a
6	BACH1	chr6:30483960-30484297	H1-hESC	embryonic stem cell:	n/a	n/a
7	BCLAF1	chr6:30483864-30484715	GM12878	blood:	n/a	n/a
8	BHLHE40	chr6:30483825-30484524	K562	blood:	n/a	n/a
9	BHLHE40	chr6:30483396-30483398	K562	blood:	n/a	n/a
10	CBX3	chr6:30483500-30485224	K562	blood:	n/a	n/a
11	CBX3	chr6:30483763-30484744	K562	blood:	n/a	n/a
12	CCNT2	chr6:30483927-30484461	K562	blood:	n/a	n/a
13	CEBPB	chr6:30483795-30484593	Hela-S3	cervix:	n/a	chr6:30483969-30483982 chr6:30483969-30483982 chr6:30483969-30483980 chr6:30483969-30483982 chr6:30484020-30484028
14	CEBPB	chr6:30483867-30484090	GM12878	blood:	n/a	chr6:30483969-30483982 chr6:30483969-30483982 chr6:30483969-30483980 chr6:30483969-30483982 chr6:30484020-30484028
15	CEBPB	chr6:30483780-30484618	HepG2	liver:	n/a	chr6:30483969-30483982 chr6:30483969-30483982 chr6:30483969-30483980 chr6:30483969-30483982 chr6:30484020-30484028
16	CEBPB	chr6:30483778-30484657	IMR90	lung:	n/a	chr6:30483969-30483982 chr6:30483969-30483982 chr6:30483969-30483980 chr6:30483969-30483982 chr6:30484020-30484028
17	CEBPB	chr6:30483666-30484760	GM12878	blood:	n/a	chr6:30483969-30483982 chr6:30483969-30483982 chr6:30483969-30483980 chr6:30483969-30483982 chr6:30484020-30484028
18	CEBPB	chr6:30483780-30484587	HepG2	liver:	n/a	chr6:30483969-30483982 chr6:30483969-30483982 chr6:30483969-30483980 chr6:30483969-30483982 chr6:30484020-30484028
19	CEBPB	chr6:30483763-30484235	ECC-1	luminal epithelium:	n/a	chr6:30483969-30483982 chr6:30483969-30483982 chr6:30483969-30483980 chr6:30483969-30483982 chr6:30484020-30484028
20	CEBPB	chr6:30483751-30484653	K562	blood:	n/a	chr6:30483969-30483982 chr6:30483969-30483982 chr6:30483969-30483980 chr6:30483969-30483982 chr6:30484020-30484028
21	CEBPB	chr6:30483738-30484181	K562	blood:	n/a	chr6:30483969-30483982 chr6:30483969-30483982 chr6:30483969-30483980 chr6:30483969-30483982 chr6:30484020-30484028
22	CEBPB	chr6:30483650-30484717	HCT-116	colon:	n/a	chr6:30483969-30483982 chr6:30483969-30483982 chr6:30483969-30483980 chr6:30483969-30483982 chr6:30484020-30484028
23	CEBPB	chr6:30483781-30484157	A549	lung:	n/a	chr6:30483969-30483982 chr6:30483969-30483982 chr6:30483969-30483980 chr6:30483969-30483982 chr6:30484020-30484028
24	CEBPB	chr6:30483775-30484518	H1-hESC	embryonic stem cell:	n/a	chr6:30483969-30483982 chr6:30483969-30483982 chr6:30483969-30483980 chr6:30483969-30483982 chr6:30484020-30484028
25	CEBPB	chr6:30483712-30484675	MCF-7	breast:	n/a	chr6:30483969-30483982 chr6:30483969-30483982 chr6:30483969-30483980 chr6:30483969-30483982 chr6:30484020-30484028
26	CEBPB	chr6:30483770-30484632	A549	lung:	n/a	chr6:30483969-30483982 chr6:30483969-30483982 chr6:30483969-30483980 chr6:30483969-30483982 chr6:30484020-30484028
27	CEBPB	chr6:30483800-30484156	HepG2	liver:	n/a	chr6:30483969-30483982 chr6:30483969-30483982 chr6:30483969-30483980 chr6:30483969-30483982 chr6:30484020-30484028
28	CEBPB	chr6:30483738-30484681	MCF-7	breast:	n/a	chr6:30483969-30483982 chr6:30483969-30483982 chr6:30483969-30483980 chr6:30483969-30483982 chr6:30484020-30484028
29	CEBPB	chr6:30483727-30484231	HepG2	liver:	n/a	chr6:30483969-30483982 chr6:30483969-30483982 chr6:30483969-30483980 chr6:30483969-30483982 chr6:30484020-30484028
30	CEBPB	chr6:30483675-30484605	A549	lung:	n/a	chr6:30483969-30483982 chr6:30483969-30483982 chr6:30483969-30483980 chr6:30483969-30483982 chr6:30484020-30484028
31	CEBPB	chr6:30483691-30484548	ECC-1	luminal epithelium:	n/a	chr6:30483969-30483982 chr6:30483969-30483982 chr6:30483969-30483980 chr6:30483969-30483982 chr6:30484020-30484028
32	CEBPB	chr6:30483677-30484722	HCT-116	colon:	n/a	chr6:30483969-30483982 chr6:30483969-30483982 chr6:30483969-30483980 chr6:30483969-30483982 chr6:30484020-30484028
33	CEBPB	chr6:30483564-30484713	K562	blood:	n/a	chr6:30483969-30483982 chr6:30483969-30483982 chr6:30483969-30483980 chr6:30483969-30483982 chr6:30484020-30484028
34	CEBPD	chr6:30483685-30484680	K562	blood:	n/a	chr6:30483970-30483981
35	CEBPD	chr6:30483694-30484681	K562	blood:	n/a	chr6:30483970-30483981
36	CEBPD	chr6:30483799-30484226	HepG2	liver:	n/a	chr6:30483970-30483981
37	CEBPD	chr6:30483746-30484204	HepG2	liver:	n/a	chr6:30483970-30483981
38	CHD1	chr6:30483673-30484685	IMR90	lung:	n/a	n/a
39	CHD1	chr6:30483753-30484533	GM12878	blood:	n/a	n/a
40	CHD2	chr6:30483921-30484540	GM12878	blood:	n/a	n/a
41	CHD2	chr6:30483896-30484286	K562	blood:	n/a	n/a
42	CHD2	chr6:30483869-30484156	H1-hESC	embryonic stem cell:	n/a	n/a
43	CTCF	chr6:30483660-30483810	GM12873	blood:	n/a	n/a
44	CTCF	chr6:30483566-30483588	MCF-7	breast:	n/a	n/a
45	CTCF	chr6:30483920-30484070	HCPEpiC	choroid plexus:	n/a	n/a
46	CTCF	chr6:30483586-30483623	GM19238	blood:	n/a	n/a
47	CTCF	chr6:30483570-30483638	GM12892	blood:	n/a	n/a
48	CTCF	chr6:30483553-30483659	GM12891	blood:	n/a	n/a
49	CTCF	chr6:30483760-30483910	AG09309	skin:	n/a	n/a
50	CUX1	chr6:30483820-30484376	GM12878	blood:	n/a	n/a

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr6:30483908-30483958	RPTEC	kidney:	n/a
2	chr6:30483908-30483958	RPTEC	kidney:	n/a
3	chr6:30483956-30484006	HCF	heart:	n/a
4	chr6:30483882-30483932	BE2_C	brain:	n/a
5	chr6:30483882-30483932	Hepatocyte	liver:	n/a
6	chr6:30483923-30483973	CMK	blood:	n/a
7	chr6:30483923-30483973	GM19239	blood:	n/a
8	chr6:30483882-30483932	NHDF-neo	bronchial:	n/a
9	chr6:30483908-30483958	Caco-2	colon:	n/a
10	chr6:30483923-30483973	HUVEC	blood vessel:	n/a
11	chr6:30483908-30483958	SKMC	muscle:	n/a
12	chr6:30483908-30483958	AG09319	gingival:	n/a
13	chr6:30483923-30483973	PrEC	prostate:	n/a
14	chr6:30483837-30483887	LNCaP	prostate:	n/a
15	chr6:30483882-30483932	IMR90	lung:	fetal
16	chr6:30483886-30483936	HRCEpiC	kidney:	n/a
17	chr6:30483886-30483936	PrEC	prostate:	n/a
18	chr6:30483886-30483936	AG04450	lung:	fetal
19	chr6:30483908-30483958	IMR90	lung:	fetal
20	chr6:30483882-30483932	SK-N-SH_RA	brain:	n/a
21	chr6:30483923-30483973	H1-hESC	embryonic stem cell:	embryo
22	chr6:30483923-30483973	SK-N-MC	brain:	n/a
23	chr6:30483908-30483958	MCF-7	breast:	n/a
24	chr6:30483923-30483973	LNCaP	prostate:	n/a
25	chr6:30483837-30483887	GM12892	blood:	n/a
26	chr6:30483956-30484006	HCT-116	colon:	n/a
27	chr6:30483956-30484006	GM12878	blood:	n/a
28	chr6:30483882-30483932	PrEC	prostate:	n/a
29	chr6:30483882-30483932	AG09319	gingival:	n/a
30	chr6:30483886-30483936	HCPEpiC	choroid plexus:	n/a
31	chr6:30483882-30483932	HCM	heart:	n/a
32	chr6:30483882-30483932	AG09309	skin:	n/a
33	chr6:30483837-30483887	Caco-2	colon:	n/a
34	chr6:30483886-30483936	GM12891	blood:	n/a
35	chr6:30483837-30483887	ProgFib	skin:	n/a
36	chr6:30483837-30483887	AG04449	skin:	fetal
37	chr6:30483923-30483973	HNPCEpiC	eye:	n/a
38	chr6:30483837-30483887	NH-A	brain:	n/a
39	chr6:30483882-30483932	SK-N-SH	brain:	n/a
40	chr6:30483837-30483887	AG09309	skin:	n/a
41	chr6:30483882-30483932	HRE	kidney:	n/a
42	chr6:30483886-30483936	HAEpiC	amniotic membrane:	n/a
43	chr6:30483923-30483973	SK-N-SH_RA	brain:	n/a
44	chr6:30483908-30483958	HepG2	liver:	n/a
45	chr6:30483956-30484006	HL-60	blood:	n/a
46	chr6:30483923-30483973	ECC-1	luminal epithelium:	n/a
47	chr6:30483886-30483936	GM12878	blood:	n/a
48	chr6:30483886-30483936	MCF10A-Er-Src	breast:	n/a
49	chr6:30483923-30483973	ovcar-3	ovarian:	n/a
50	chr6:30483886-30483936	NT2-D1	testis:	n/a

No.	Distal block	Cell Line	Cell type
1	chr6:30482665..30485731-chr6:30524141..30525971,3	MCF-7	breast:
2	chr6:30481743..30485761-chr6:30582102..30585444,5	K562	blood:
3	chr6:30455872..30460443-chr6:30482529..30486009,9	K562	blood:
4	chr6:30482719..30486624-chr6:30535507..30541696,8	K562	blood:
5	chr6:30483905..30485578-chr6:30685111..30687168,2	K562	blood:
6	chr6:30483908..30485878-chr6:30522837..30525858,6	K562	blood:
7	chr6:30481563..30487862-chr6:30521673..30526487,12	K562	blood:
8	chr6:30482934..30485578-chr6:30684677..30686611,2	K562	blood:
9	chr6:30482834..30484451-chr6:30614992..30617203,2	MCF-7	breast:
10	chr6:30455700..30459615-chr6:30482438..30485842,11	MCF-7	breast:
11	chr6:30456365..30459515-chr6:30480416..30486332,6	MCF-7	breast:
12	chr6:30456467..30458810-chr6:30482542..30485985,4	K562	blood:
13	chr6:30482489..30485588-chr6:30582296..30586114,5	K562	blood:

Variant related genes	Relation type
ENSG00000235781	TF binding region
ENSG00000235781	CpG island
ENSG00000204569	chromatin interactions
ENSG00000204590	chromatin interactions
ENSG00000204564	chromatin interactions
ENSG00000204576	chromatin interactions
ENSG00000137337	chromatin interactions
ENSG00000204574	chromatin interactions
ENSG00000222894	chromatin interactions
ENSG00000204568	chromatin interactions
ENSG00000204592	chromatin interactions
ENSG00000266183	chromatin interactions

Extended variants
information (count: 22 )
Associated
traits (count: 120 )

Variant overlapped rSNPs/rCNVs (count:22 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs543468507	chr6:30483205-30483206	Active TSS Flanking Active TSS Weak transcription Enhancers Bivalent Enhancer Bivalent/Poised TSS	TF binding region Chromatin interactive region	11 gene(s)	Overlapped CNVs	n/a
2	rs573377191	chr6:30483283-30483284	Active TSS Flanking Active TSS Weak transcription Enhancers Bivalent Enhancer Bivalent/Poised TSS	TF binding region Chromatin interactive region	11 gene(s)	Overlapped CNVs	n/a
3	rs550416623	chr6:30483300-30483301	Active TSS Flanking Active TSS Weak transcription Enhancers Bivalent Enhancer Bivalent/Poised TSS	TF binding region Chromatin interactive region	11 gene(s)	Overlapped CNVs	n/a
4	rs545206834	chr6:30483304-30483305	Active TSS Flanking Active TSS Weak transcription Enhancers Bivalent Enhancer Bivalent/Poised TSS	TF binding region Chromatin interactive region	11 gene(s)	Overlapped CNVs	n/a
5	rs565356735	chr6:30483339-30483340	Active TSS Flanking Active TSS Weak transcription Enhancers Bivalent Enhancer Bivalent/Poised TSS	TF binding region Chromatin interactive region	11 gene(s)	Overlapped CNVs	n/a
6	rs374097923	chr6:30483365-30483366	Active TSS Flanking Active TSS Weak transcription Enhancers Bivalent Enhancer Bivalent/Poised TSS	TF binding region Chromatin interactive region	11 gene(s)	Overlapped CNVs	n/a
7	rs186138623	chr6:30483415-30483416	Active TSS Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	11 gene(s)	Overlapped CNVs	n/a
8	rs66901725	chr6:30483449-30483450	Active TSS Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	11 gene(s)	Overlapped CNVs	n/a
9	rs188990210	chr6:30483484-30483485	Active TSS Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	11 gene(s)	Overlapped CNVs	n/a
10	rs181383036	chr6:30483490-30483491	Active TSS Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	11 gene(s)	Overlapped CNVs	n/a
11	rs561175183	chr6:30483500-30483501	Active TSS Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	11 gene(s)	Overlapped CNVs	n/a
12	rs9262076	chr6:30483502-30483503	Active TSS Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	11 gene(s)	Overlapped CNVs	n/a
13	rs529967087	chr6:30483504-30483505	Active TSS Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	11 gene(s)	Overlapped CNVs	n/a
14	rs371108006	chr6:30483511-30483512	Active TSS Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	11 gene(s)	Overlapped CNVs	n/a
15	rs544481653	chr6:30483513-30483514	Active TSS Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	11 gene(s)	Overlapped CNVs	n/a
16	rs377711664	chr6:30483554-30483555	Active TSS Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	11 gene(s)	Overlapped CNVs	n/a
17	rs2534811	chr6:30483680-30483681	Active TSS Flanking Active TSS Weak transcription Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	11 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
18	rs117725140	chr6:30483761-30483762	Active TSS Flanking Active TSS Weak transcription Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	11 gene(s)	Overlapped CNVs	n/a
19	rs185491815	chr6:30483797-30483798	Active TSS Flanking Active TSS Weak transcription Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	11 gene(s)	Overlapped CNVs	n/a
20	rs148860875	chr6:30483807-30483808	Active TSS Flanking Active TSS Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription	TF binding region Chromatin interactive region	11 gene(s)	Overlapped CNVs	n/a
21	rs367612462	chr6:30483880-30483881	Active TSS Flanking Active TSS Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription	TF binding region CpG island Chromatin interactive region	11 gene(s)	Overlapped CNVs	n/a
22	rs7746096	chr6:30483919-30483920	Active TSS Flanking Active TSS Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription	TF binding region CpG island Chromatin interactive region	11 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance

Variant related diseases (count:120)

Disease	PMID	Source
Acute lymphoblastic leukemia	22237106	CNVD
Follicular lymphoma	20505157	CNVD
Glioblastoma multiforme	21080181	CNVD
Ewing''s sarcoma	21437220	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Leukemia	21518781	CNVD
Cancer	21637783	CNVD
Facial dysmorphism	22105932	CNVD
Medulloblastoma	21979893	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Endometrial cancer	22040021	CNVD
Acute myeloid leukemia	16864856	CNVD
Breast cancer	21264507	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	16751803	CNVD
Bladder cancer	19088036	CNVD
Wilms tumour	21544195	CNVD
Uveal melanoma	21693616	CNVD
Biliary cancer	19435499	CNVD
Malaria	21533027	CNVD
Retinoblastoma	19183342	CNVD
Acute myeloid leukemia	20729466	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Prostate cancer	18632612	CNVD
Breast cancer	21858162	CNVD
Lung cancer	18438408	CNVD
Ewing''s sarcoma	17952124	CNVD
Autism	21448237	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Cancer	20164919	CNVD
Melanoma	18172304	CNVD
Breast cancer	22844521	CNVD
HIV/AIDS	22844521	CNVD
Ovarian cancer	22844521	CNVD
Prostate cancer	22844521	CNVD
Psoriasis	22844521	CNVD
Rheumatoid arthritis	22844521	CNVD
Sclerosis systemic	22844521	CNVD
Systemic lupus erythematosus	22844521	CNVD
Breast cancer	22522925	CNVD
Ovarian cancer	21781307	CNVD
Breast cancer	21552322	CNVD
Immune disease	21076436	CNVD
Autoimmune disease	19135723	CNVD
Systemic lupus erythematosus	17953491	CNVD
Recurrent Infections	22737222	CNVD
Systemic lupus erythematosus	21904924	CNVD
Ependymoma	19289631	CNVD
Gestational infection	22844521	CNVD
Head circumference	22844521	CNVD
Infertility	22844521	CNVD
Recurrent birth weight diabetes	22844521	CNVD
Obesity	22844521	CNVD
Recurrent pregnancy loss	22844521	CNVD
Intellectual disability	21811512	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Congenital anomalies of the kidney and urinary tract	18694510	CNVD
Nasopharyngeal cancer	22815911	CNVD
Hepatocellular carcinoma	16750200	CNVD
Basal cell lymphoma	21115979	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Autism	22495311	CNVD
Cancer	16790693	CNVD
Cervical cancer	21062161	CNVD
Breast cancer	21785460	CNVD
Esophageal adenocarcinoma	18820669	CNVD
Systemic lupus erythematosus	17503323	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Urothelial carcinoma	18382360	CNVD
Cancer	21183584	CNVD
Hodgkin''s lymphoma	17606441	CNVD
small cell lung cancer	20016488	CNVD
Renal cell carcinoma	18765545	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Gastric cancer	17908304	CNVD
Metanephric adenoma	20802469	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Schizophrenia	19571808	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Neuroblastoma	16790693	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
abnormal development	18461090	CNVD
Melanoma	17363583	CNVD
Myelofibrosis	22110671	CNVD
Breast cancer	16397240	CNVD
Retinoblastoma	22278416	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Systemic lupus erythematosus	20877625	CNVD
Cleidocranial dysplasia	18696259	CNVD
Holoprosencephaly	21359414	CNVD
Liposarcoma	21253554	CNVD
Uveal melanoma	20484589	CNVD
Fibroblasts	20926602	CNVD
Breast cancer	21364760	CNVD
Lung cancer	21569311	CNVD
Systemic lupus erythematosus	19279649	CNVD
Retinoblastoma	16790693	CNVD
Acute myocardial infarction	18032375	CNVD
Renal cell carcinoma	19150565	CNVD
Systemic lupus erythematosus	19591781	CNVD
Attention deficit hyperactivity disorder	19287146	CNVD
Autism	19287146	CNVD
Erythema nodosum in leprosy	19287146	CNVD
Henoch-schoenlein purpura	19287146	CNVD
Liver cirrhosis	19287146	CNVD
Systemic lupus erythematosus	19287146	CNVD
Congenital adrenal hyperplasia	18478071	CNVD
Systemic lupus erythematosus	19287147	CNVD
Osteosarcoma	16790693	CNVD

Chromatin state (count:225 , 50 per page) page: 1 2 3 4 5

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:30468800-30483800	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
2	chr6:30476600-30485200	Weak transcription	Small Intestine	intestine
3	chr6:30477000-30483600	Weak transcription	Foreskin Fibroblast Primary Cells skin02	Skin
4	chr6:30477400-30483200	Enhancers	Primary T cells fromperipheralblood	blood
5	chr6:30477400-30483200	Enhancers	Primary T helper 17 cells PMA-I stimulated	--
6	chr6:30477400-30483400	Enhancers	Primary T helper cells fromperipheralblood	blood
7	chr6:30477400-30483600	Weak transcription	Foreskin Fibroblast Primary Cells skin01	Skin
8	chr6:30477400-30483600	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin
9	chr6:30477400-30483600	Weak transcription	NHEK	skin
10	chr6:30477400-30483800	Weak transcription	HMEC	breast
11	chr6:30477600-30483200	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
12	chr6:30477600-30483600	Enhancers	Primary T regulatory cells fromperipheralblood	blood
13	chr6:30478200-30483400	Weak transcription	Rectal Mucosa Donor 31	rectum
14	chr6:30478600-30483600	Weak transcription	Placenta Amnion	Placenta Amnion
15	chr6:30479200-30483600	Weak transcription	Skeletal Muscle Female	skeletal muscle
16	chr6:30479400-30483200	Weak transcription	Sigmoid Colon	Sigmoid Colon
17	chr6:30479600-30483200	Enhancers	Primary T cells from cord blood	blood
18	chr6:30479600-30483200	Weak transcription	Primary T cells effector/memory enriched fromperipheralblood	blood
19	chr6:30479600-30483600	Enhancers	Primary T helper naive cells fromperipheralblood	blood
20	chr6:30480800-30483200	Weak transcription	Lung	lung
21	chr6:30481000-30483200	Weak transcription	GM12878-XiMat	blood
22	chr6:30481600-30483600	Enhancers	K562	blood
23	chr6:30481800-30483600	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
24	chr6:30482000-30483200	Enhancers	Primary T killer naive cells fromperipheralblood	blood
25	chr6:30482000-30483600	Enhancers	Primary monocytes fromperipheralblood	blood
26	chr6:30482000-30483600	Enhancers	Primary T helper naive cells from peripheral blood	blood
27	chr6:30482400-30483600	Enhancers	Primary T killer memory cells from peripheral blood	blood
28	chr6:30482400-30485000	Flanking Active TSS	Primary neutrophils fromperipheralblood	blood
29	chr6:30482600-30483200	Enhancers	H1 Cell Line	embryonic stem cell
30	chr6:30482600-30483200	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
31	chr6:30482600-30483600	Enhancers	Fetal Thymus	thymus
32	chr6:30482600-30483800	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
33	chr6:30482600-30483800	Weak transcription	HSMM	muscle
34	chr6:30482800-30483200	Weak transcription	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
35	chr6:30482800-30483200	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Female	--
36	chr6:30482800-30483200	Enhancers	Primary mononuclear cells fromperipheralblood	Blood
37	chr6:30482800-30483200	Enhancers	Adipose Nuclei	Adipose
38	chr6:30482800-30483200	Bivalent Enhancer	Brain Angular Gyrus	brain
39	chr6:30482800-30483400	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
40	chr6:30482800-30483400	Flanking Active TSS	HUES48 Cell Line	embryonic stem cell
41	chr6:30482800-30483400	Flanking Active TSS	HUES6 Cell Line	embryonic stem cell
42	chr6:30482800-30483400	Flanking Active TSS	Primary T helper cells PMA-I stimulated	--
43	chr6:30482800-30483400	Enhancers	Thymus	Thymus
44	chr6:30482800-30483400	Enhancers	Spleen	Spleen
45	chr6:30482800-30483400	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
46	chr6:30482800-30483600	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
47	chr6:30482800-30483600	Active TSS	Stomach Smooth Muscle	stomach
48	chr6:30482800-30483600	Bivalent Enhancer	HepG2	liver
49	chr6:30482800-30483800	Enhancers	Primary T helper memory cells from peripheral blood 2	blood
50	chr6:30482800-30483800	Enhancers	Primary T helper memory cells from peripheral blood 1	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links